Generative AI in medical writing: co-author or tool?

Richard Armitage
DOI: https://doi.org/10.3399/bjgp24x736605
2024-03-01
British Journal of General Practice
Abstract:ChatGPT is now 1 year old. This large language model (LLM), which was created by OpenAI and made freely available to the public on 30 November 2022, made such broad and disrupting impact before its first birthday that many believe the dawn of generative AI constitutes a technological era of similar import to electrical power.1 In late 2023, while GPT-4 (the latest model of ChatGPT) still leads the user-friendly LLM landscape, it faces growing competition from the likes of Meta's Llama, Microsoft's Bing AI, Quora's Poe, Anthropic's Claude-2, and Google's Bard. The generative power of these AI tools is rapidly disrupting almost every industry, including clinical medicine, healthcare and health systems, and medical writing.2 Indeed, authors who hopefully submit their manuscripts to the The Lancet and its sub-journals are now required to make a declaration regarding their use of generative AI and AI-assisted technologies in their work, attesting to their responsibility for the article contents. The Lancet declares that generative AI is not an author, and dictates that 'these technologies should only be used to improve readability and language' .3 But are these statements — the first a factual claim, the second a normative assertion — entirely true? Let's deal with each in turn. ...
medicine, general & internal,primary health care
What problem does this paper attempt to address?